fbpx
Connect with us

CBD CONDITIONS & TREATMENTS

Cannabis Science Inc (OTCMKTS:CBIS) Enters A New Research Accord With Dana-Farber Cancer Institute To Conduct Research On Justicia Plant Extract To Cure Blood Disorders

Published

on

Cannabis Science Inc (OTCMKTS:CBIS) has announced the signing of a new research accord with Dana-Farber Cancer Institute. Under the agreement, the research will be conducted on the Justicia plant extract to find a remedy to cure blood disorders.

The company has already identified a myriad of products for development, considering the current research on Justicia plant extract. The products comprise a nutraceutical for blood health. It is a biomaterial that could act as a substitute for the blood.

Cannabis Science to pay $200,000

Cannabis Science entered a pact on November 15, 2018, with Dana-Farber. The agreement is effective from October 19, 2018, and valid for 12 months. As per the agreed terms of this research collaboration agreement (RCA) and based on the performance of research, Cannabis Science will pay a sum of $200,000 to Dana-Farber.

Justicia belongs to the Acanthaceae family. The current accord is to investigate the Justicia extract to cure a variety of blood disorders. The RCA will also focus on the other potential uses of an extract of Justicia plant.

Chief Executive Officer and President of Cannabis Science, Raymond C. Dabney said the company signed the first agreement in January 2017 with Dana-Farber. In January 2018, it signed a new accord with Dana-Farber for a consideration of $1.8 million. The new RCA is valid for five years.

Investigation of cannabinoids on cancer

In the initial stage, Cannabis Science, along with Dana-Farber, would engage in the investigation of cannabinoids effect without or with radiotherapy on pancreatic and lung cancers. An outcome of the investigation on the proprietary extract of Justicia plant would offer treatment to millions of patients worldwide. Dr. Allen Herman, the former CMO, has initiated this collaboration. Unfortunately, he expired last year. The CEO is pushing forward this initiative in the memory of Allen.

Forms Cannabis Sciences Canada Inc

Cannabis Science has created Cannabis Sciences Canada Inc for an expansion into the Canadian Market. It is in advanced negotiations using the existing license holders to acquire licenses and land for cannabis and medical hemp cultivation in Canada. The acquisitions would help Cannabis Science to expedite drug development and product launches in Canada.

CBD CONDITIONS & TREATMENTS

Supreme Cannabis Company Inc (OTCMKTS:SPRWF) Signs An Accord To Become A Supplier Of Vaporizable Products To Pax Era In Canada

Published

on

Supreme Cannabis Company Inc (OTCMKTS:SPRWF) has entered a pact to supply vaporizable products in Canada. Supreme Cannabis joined hands with Pax Labs to enter the vaporizer market in Canada with their proven brands.

7Acres to supply cannabis oil pods

Pax has selected 7Acres, a wholly owned subsidiary of Supreme Cannabis, to supply cannabis oil pods for Pax Era. The company already sold more than 1.5 million devices across the world. It is one of the reputed firms to supply pen and pod systems in the US. The proven brand development ability of Supreme Cannabis along with high quality cannabis flower provides a unique opportunity in the market. The alliance with Pax will improve the growth of vaporizer products.

Chief Executive Officer of Supreme Cannabis, Navdeep Dhaliwal said the company is pleased to partner with Pax to offer excellent vaporizing experience to the customers. 7Acres will supply oils extracted from cannabis flower for Pax Era, the premium vaporizer, in North America.

Navdeep further said 7Acres has established itself as a leader in the supply of premium quality cannabis flower on a large scale in Canada. The company is now expanding the Canada brand into innovative product categories.  It will maintain the same quality to the valued customers. The company is excited to work PAX to offer premium brand experience to the customers on Pax Era platform.

Sells vaporizer oil in Era-compatible pods

As per the terms of the accord, the company will sell vaporizer oil under the 7Acres brand in Era compatible pods. Supreme Cannabis will also supply pods under different brands for Pax Era. 7Acres expects to sell Pax Era pods under the 7Acres brand in areas where Supreme Cannabis holds provincial supply accords.

Welcomes Health Canada final regulations

Supreme Cannabis has welcomed final regulations released by Health Canada. Under the newly released regulations, licensed holders are allowed production and sale of cannabis extracts, edibles, and topicals. Supreme Cannabis would develop good quality cannabis extracts that comprise oils, concentrates, vaping liquids, and tinctures under its own brands. The alliance with Pax allows Supreme Cannabis to enter the cannabis category.

Supreme Cannabis also plans to supply oils and extracts under its pact with Khalifa Kush Enterprises Canada ULC. The company’s proposed takeover of Blissco Cannabis Corp allows engaging in new product development.

Continue Reading

CBD CONDITIONS & TREATMENTS

Cresco Labs Inc (OTCMKTS:CRLBF) Inaugurates VidaCann Dispensaries In Jacksonville And Pensacola And Expands Retail Footprint In Florida

Published

on

Cresco Labs Inc (OTCMKTS:CRLBF) has inaugurated new Vidacann medical cannabis dispensaries in Jacksonville and Pensacola cities in Florida. Co-founder and Chief Executive Officer of Cresco, Charlie Bachtell said since the takeover announced in March 2019, Vidacann has expanded its retail footprint in the state. The company will close the acquisition of Vidacann within 90 days.

12 dispensaries in Florida

With the opening of two new medical cannabis dispensaries, Vidacann now has 12 dispensaries in Florida. The most advanced and one of the biggest medical cannabis providers in Florida, Vidacann will improve the retail presence in the two biggest cities: Jacksonville and Pensacola by opening new dispensaries. Cresco will have the fifth biggest retail dispensaries network in Florida.

Cresco expects a weekly patient growth of 10,000 in Florida with the opening of new dispensaries in Pensacola and Jacksonville. It plans to increase the count of dispensaries in the state to 20 by 2029.

Cresco sets a revenue target of $1 billion

Cresco has become one of the multi-state operators in just 30 days with a couple of takeovers recently. The company announced accord to takeover Origin House in April 2019. As per the terms of the deal, the shareholders of Origin House will get 0.8428 shares of Cresco for each of their share in Origin House. The deal is valued at $1.1 billion CAD. It makes the biggest public company takeover in cannabis space in the US for Cresco.

Cresco has set a revenue target of $1 billion by the year 2021. Its Q3 2019 revenues are reported at $12 million. The company aims to become one of the biggest cannabis players in the world.

Cresco owns licenses in 51 retail locations and have access to 11 states following the takeover of Vidacann. The takeover of Origin House provides Cresco access to California distribution network of 50 brand relationships and 500 dispensary partners. Revenues from California market is expected at $7.7 billion by the year 2022.

Cresco will have access to New York, Michigan and Florida. These states together with California would offer a better opportunity for the company. With all these developments in place, the valuation of the stock are estimated at $4.1 billion.

Continue Reading

CBD CONDITIONS & TREATMENTS

Future Farm Technologies Inc (OTCMKTS:FFRMF) Completes Indoor Cultivation Stage And Expects To Produce 130,000 Pounds Of Biomass From 2019 Crop

Published

on

Future Farm Technologies Inc (OTCMKTS:FFRMF) has completed 2019 hemp for wellness crop’s indoor cultivation stage. The company is ready to transplant 200,000 seedlings in Hersey, Maine based 100 acre facility.

Expects yield of 130,000 pounds

Future Farm expects an output of 130,000 pounds of biomass from 2019 hemp crop. The company will transplant the seedlings at right time in the climate controlled indoor facility. Perfect timing of the seedlings will help to grow healthy plants and get higher yield of cannabidiol and other valuable bi-products.

Zero THC products

Future Farm will seek the help of processing providers to process biomass produced from the crop. The company will supply extracts, isolates, high quality distillates, zero THC products, and water-soluble products to the product manufacturers.

The Managers (Growing Operation) of Future Farm, Nate Gray and Zachary Lapan said they are confident of achieving a bumper 2019 crop with the application of experience gained in the inaugural 2018 harvest and processing.

Issues an update on Florida operations

Future Farm said its operations in Apopka, Florida based White Sand Nursery are in full swing. It started the 3 truckloads of spring accent plants shipments per week in March 2019 to one of the biggest customers in White Sand. The company expected to ship 850,000 3.5” plants in the first week of June 2019. Expected revenues from these shipments are estimated at $500,000. Future Farm is planning to fulfill the pre-booked orders of 845,000 plants from clients across the nation in fall season.

Chief Executive Officer of Future Farm, William Gildea said he is pleased with the accomplishments achieved by the management at White Sands. He is thrilled to ship truckloads of good quality products in a healthy condition.

Enters pact with Northeast Processing

Future Farm has signed an accord with Vermont based Northeast Processing for the processing, testing and packaging of its hemp cultivated in a Maine based 100 acre facility in 2019.

Northeast converts the Future Farm produced hemp biomass into CBD isolate, whole plant extract, and CBD distillate in just 4 months. Future Farm is searching for customers to supply its isolate, distillate and full spectrum extracts for wellness and health products.

Continue Reading
Advertisement
Advertisement
Advertisement






Trending Stories